HArmonyCa Nodules: What to Do When a Hybrid Collagen-Stimulator Filler Leaves Lumps

A lot of people arrive like this: they had HArmonyCa, liked the result, and then a few months later started feeling firm little lumps at certain points on the face. They go back to where it was done, and the answer is often "that's rare, just massage it."

Let me say the honest part first. HArmonyCa's published nodule rate really is low, and that deserves to be said plainly. The issue isn't that it lumps easily. The issue is that it's a hybrid material, and once a lump does form, the logic for handling it is nothing like handling plain hyaluronic acid (HA). You assume "it has HA in it, so it can be dissolved" — and that's only half true.

What HArmonyCa actually is, and why "dual action"

HArmonyCa is a hybrid injectable from Allergan with two things mixed together: about 70% crosslinked hyaluronic acid gel, and about 30% microspheres of CaHA (calcium hydroxyapatite, the same material in Radiesse), roughly 25 to 45 microns across, plus a little lidocaine for comfort.

The selling point is "two jobs in one injection." The HA does the immediate filling and lifting, so you see something the day you walk out. The CaHA microspheres slowly stimulate your own collagen, which carries the support over the following months to a year or two. The design itself is clever; the manufacturer calls the mechanism DART, its dual-action technology.

And the root of the lump problem lives right there too. Anything that stimulates collagen is, by definition, asking your body to react to a foreign object. Most people react just right. A few react too much, the collagen grows in excess and unevenly, and that becomes a nodule.

Key point: Any material that stimulates collagen carries some chance of an over-reaction that turns into a lump. HArmonyCa's nodule risk is counted as "low" — but low is not zero, and it certainly doesn't mean a lump will be easy to deal with if it happens.

The other side of "dual action": how lumps form, and why the delayed risk is underrated

Start with the published numbers, because they shape how you should read the risk. A 2024 retrospective study in PRS Global Open (PMID 38348461, 403 participants) reported implant-site nodules in roughly 1.2% to 2.1% of cases, most of them noninflammatory and early-onset within two months, looking more like material accumulation. A separate 2024 real-world retrospective (PMID 39360597, 129 patients) put nodules at 0.8%.

That sounds reassuring. There are two limits you should know about, though.

First, the follow-up in these studies is still fairly short, and several are industry-related or industry-funded. For a product this new, the truly delayed nodules can take many months or a year-plus to surface, and current data hasn't captured that tail yet. Second, at the level of the whole CaHA-type biostimulator class, delayed nodules are a documented phenomenon, not a surprise. So "looks low right now" and "definitely safe long term" are two different statements.

What I see in clinic tends to be the person who landed inside that one or two percent. To the statistics she's a rare case. To herself it's a hundred percent.

The "half-reversible" trap of hybrid materials: HA dissolves, CaHA does not

This is the part I most want you to remember.

A lot of patient education out there says: "HArmonyCa has HA in it, so if you're unhappy you can dissolve it with hyaluronidase." That sentence is only about thirty percent right. Hyaluronidase is an enzyme made specifically to break down hyaluronic acid, and the only thing it can dissolve is the HA portion. The CaHA microspheres are not hyaluronic acid, so hyaluronidase does nothing to them; and the collagen your body has already grown around the CaHA is even further from anything the enzyme can touch.

In other words, after you dissolve the HA half, the hard core is often still sitting there.

So a hybrid material creates an illusion of "reversible." What's reversible is the HA. What isn't reversible is the actual problem. This runs along the same line as how we handle plain Radiesse (CaHA) complications, which you can read alongside this in Radiesse complications and calcified lumps; and for why dissolver injections so often do nothing, 7 reasons hyaluronidase fails goes deeper.

Why "let's try steroid first" is often not a good answer

When a lump appears, a common first move is to inject steroid into the area to suppress inflammation. It sounds reasonable. In practice it's a decision that's easy to regret.

Steroid may settle an inflammatory nodule, but against a HArmonyCa lump whose core is stimulated collagen, it runs into an awkward fact: steroid causes tissue to atrophy. It won't necessarily shrink that hard core, yet it will atrophy the normal fat and collagen sitting next to the lump first. And its effect is ongoing, not a one-and-done — after you stop, the tissue keeps drifting toward a depression for a while longer.

I've seen too many faces where the lump stood firm while the area beside it caved in. What started as a bump problem becomes a bump that's still there, plus a new hollow — harder to fix than the original.

Key point: With a collagen-driven lump, the thing to fear isn't "it didn't work" but "the normal tissue next to it collapsed first." If steroid is used at all, the dose, the location and the number of sessions have to be very conservative, and you should think through whether atrophy can be reversed before you start. I lay this out bluntly in steroid injection and the risk of tissue atrophy.

If you've already been advised to have steroid, I'd ask you not to rush into treating the whole face. Better to test a small area first and watch the response than to treat a large patch at once — if the reaction is atrophy, doing the whole face together costs far too much.

From watching to minimally invasive removal: a decision ladder for lumps

Not every lump needs an immediate intervention. There's an order to handling them, from light to heavy, and the point is knowing which rung you're on and when to step down.

1. Type it before you treat it. Use ultrasound to see clearly whether this lump is inflammatory, noninflammatory, or an already-formed fibrous nodule. Get the type wrong and the whole path that follows goes wrong.
2. Early, mild, noninflammatory ones get time and conservative observation first. Some early material accumulation settles on its own, and this is not the stage to start injecting things to "fix" it.
3. Ones that keep growing or repeatedly inflame may, after an in-person assessment, call for intralesional medication or gentle physical release — but every step has to weigh the cost to the surrounding tissue.
4. Stable, stubborn fibrous nodules with a clear palpable border are where ultrasound-guided single-pinhole physical extraction earns its place. Under real-time imaging you locate that core and take the CaHA microspheres and the overgrown fibrous tissue out through one pinhole, instead of adding more material or chemically chasing something that won't dissolve.

Why is physical removal especially central for a hybrid? Because of what we covered above: CaHA and collagen, the two things that are the real core of the lump, can't be dissolved by any drug. The reversible HA leaves on its own, and what stays behind is the part you have to take out. That's why we position extraction as the last resort for hybrid collagen-stimulator lumps, not the first step.

To understand the causes and treatment framework for this whole class of collagen-stimulator lumps, see the full collagen-stimulator lumps overview.

Before you inject, and after: what you can do

If you're still considering HArmonyCa: choose a doctor with experience who will assess with ultrasound, and keep the dose conservative and staged rather than filling a lot at once. Over-injection is the single biggest amplifier of nodule risk, and that holds for every collagen stimulator.

If you've already had it and are starting to feel lumps: don't aggressively massage them or rush to have something injected. Note when each one appeared, where it is, how firm it is, whether it's red or swollen, and find a doctor who will look properly with ultrasound and tell you honestly which lump should wait and which should come out. With a hybrid lump, the worst mistake is using the method for HA to attack a problem that isn't HA.

I tell patients very plainly: HArmonyCa isn't a bad product, and its nodule rate genuinely isn't high. But if you turn out to be one of the few, remember it's a hybrid — the half that dissolves was never the problem; the half that doesn't is. See it clearly and treat it the right way, and you won't drag a small lump into an uneven face.

If you can feel a lump you're unsure about, or you've been treated and the result wasn't good, you're welcome to come in for an assessment with Dr. Ta-Ju Liu. We'll look with ultrasound first, then decide the next step together.